Alkermes plc Ordinary Shares (ALKS)
Stock · NASDAQ · Health Care
$47.41as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$33.34
Industry
Biotechnology: Pharmaceutical Preparations
Alkermes plc Ordinary Shares Competitors
Chosen by industry and closest market cap.
- ALKSAlkermes plc Ordinary Shares$47.41▼ 3.05%Market cap $8.31BP/E —
- SYRESpyre Therapeutics Inc. Common Stock$90.4▼ 3.43%Market cap $8.35BP/E —$14.51$110.18
- CYTKCytokinetics Incorporated Common Stock$72.17▼ 7.36%Market cap $9.51BP/E —$35.22$88.31
- COGTCogent Biosciences Inc. Common Stock$34.68▼ 6.50%Market cap $6.64BP/E —$11.6$43.73
- MIRMMirum Pharmaceuticals Inc. Common Stock$97.44▼ 2.32%Market cap $6.38BP/E —$63.23$130
- SMMTSummit Therapeutics Inc. Common Stock$13.71▼ 4.33%Market cap $10.41BP/E —$12.07$29.23
- ERASErasca Inc. Common Stock$18.03▼ 7.49%Market cap $6.11BP/E —$1.33$24.28
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ALKS Alkermes plc Ordinary Shares | $8.31B | — | $47.41 | ▼ 3.05% | |
| SYRE Spyre Therapeutics Inc. Common Stock | $8.35B | — | $90.4 | ▼ 3.43% | $14.51$110.18 |
| CYTK Cytokinetics Incorporated Common Stock | $9.51B | — | $72.17 | ▼ 7.36% | $35.22$88.31 |
| COGT Cogent Biosciences Inc. Common Stock | $6.64B | — | $34.68 | ▼ 6.50% | $11.6$43.73 |
| MIRM Mirum Pharmaceuticals Inc. Common Stock | $6.38B | — | $97.44 | ▼ 2.32% | $63.23$130 |
| SMMT Summit Therapeutics Inc. Common Stock | $10.41B | — | $13.71 | ▼ 4.33% | $12.07$29.23 |
| ERAS Erasca Inc. Common Stock | $6.11B | — | $18.03 | ▼ 7.49% | $1.33$24.28 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.